NLRP3 and early-onset autosomal dominant Alzheimer disease: Increased NLRP3 inflammasome activity also accelerates up the development of several inflammatory conditions, such as cryopyrin-associated periodic syndrome, arthritis, atherosclerosis, type 2 diabetes, Alzheimer’s disease, and cancers [43–45].